Established in 2001 and headquartered in Irvine, California, HealthBanks Group operates HealthBanks Biotech (USA) and its sister stem cell banking companies around the world. Along with possessing FDA registration and a State of California Department of Health license, we comply with the current AABB standards for cell therapy, the California Health and Safety Code, the California Business and Professional Code, and the California Code of Regulations. Our California license allows us to do blood, tissue, clinical testing, and biologics, and the New York license permits tissue banking. A leader and innovator in the cell banking industry, we are the only US-based company to offer stem cell, immune cell, and cord blood banking services. Using premium automation technology and the BioArchive® liquid nitrogen cryopreservation and storage system, we can preserve umbilical cord blood stem cells, umbilical cord tissue stem cells, and immune cells for an indefinite period. The benefit of banking stem cells and immune cells early on is that the decision will enable you and your family to prevent and treat chronic health conditions that might arise as your natural immune system weakens with age. By performing cord blood transplants, it is now possible to treat over 80 diseases, including cancers and metabolic, immune system, and blood disorders. The use of immune cells has revolutionized immunotherapy forms like CAR T-cell therapy against some forms of leukemia and lymphoma. Further advances in stem cell research and cell and gene therapies may lead to treatments for many other currently incurable health conditions. To know more about our stem cell and immune cell banking services, visit us at https://healthbanks.us/technology/ & https://healthbanks.us/msc-cord-tissue-processing/.